Helen M. Thackray
2021 - BioCryst Pharmaceuticals
Compensation breakdown
| Bonus | $236,500 |
|---|---|
| Non-Equity Incentive Plan | $298,125 |
| Option Awards | $4,395,101 |
| Salary | $425,125 |
| Stock Awards | $1,519,920 |
| Other | $6,625 |
| Total | $6,881,396 |
Thackray received $4.4M in option awards, accounting for 64% of the total pay in 2021.
Thackray also received $236.5K in bonus, $298.1K in non-equity incentive plan, $425.1K in salary, $1.5M in stock awards and $6.6K in other compensation.
Rankings
In 2021, Helen M. Thackray's compensation ranked 1,791st out of 12,415 executives tracked by ExecPay. In other words, Thackray earned more than 85.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,791 out of 12,415 | 86th |
Division Manufacturing | 666 out of 5,505 | 88th |
Major group Chemicals And Allied Products | 250 out of 2,375 | 90th |
Industry group Drugs | 211 out of 2,096 | 90th |
Industry Biological Products, Except Diagnostic Substances | 58 out of 449 | 87th |
Pay ratio
| Helen M. Thackray's Pay | $6,881,396 |
|---|---|
| Median Employee's Pay | $273,522 |
| Pay Ratio | 25to 1 |
In 2021, the annual total compensation of Helen M. Thackray was $6,881,396.
The annual total compensation of the median employee at BioCryst Pharmaceuticals was $273,522.
The ratio of Helen M. Thackray's pay to the pay of median employee was therefore 25 to one.
Thackray's colleagues
We found five more compensation records of executives who worked with Helen M. Thackray at BioCryst Pharmaceuticals in 2021.
2021
Megan Sniecinski
BioCryst Pharmaceuticals
Former Chief Business Officer
2021
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2021
Anthony Doyle
BioCryst Pharmaceuticals
Chief Financial Officer
2021
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
2021
Yarlagadda Babu
BioCryst Pharmaceuticals